The Intersurgical i-flo™ nasal cannula is a single use patient interface intended for the delivery of High Flow Oxygen Therapy (HFOT). It is intended to treat adult patients with hypoxemic respiratory failure and intended for use in a hospital environment and is available in three sizes.
HFOT has become a key mode of respiratory support in patients with hypoxemic respiratory failure and is considered to offer a number of benefits versus more conventional oxygen therapies. These benefits have been shown to include:
• improved oxygenation
• reduced work of breathing
• improved secretion clearance
• improved patient tolerance
• avoidance of intubation1
1. Masaji Nishimura. High-Flow Nasal Cannula Oxygen Therapy in Adults: Physiological Benefits, Indication, Clinical Benefits, and Adverse Effects. Resp.Care 2016 Apr;61(4):529-41